PE20070707A1 - Compuestos de tetrahidro-pirrolizinona como inhibidores de lfa-1 - Google Patents
Compuestos de tetrahidro-pirrolizinona como inhibidores de lfa-1Info
- Publication number
- PE20070707A1 PE20070707A1 PE2006001210A PE2006001210A PE20070707A1 PE 20070707 A1 PE20070707 A1 PE 20070707A1 PE 2006001210 A PE2006001210 A PE 2006001210A PE 2006001210 A PE2006001210 A PE 2006001210A PE 20070707 A1 PE20070707 A1 PE 20070707A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- compounds
- alkynyl
- aryl
- substituted
- Prior art date
Links
- 102100022339 Integrin alpha-L Human genes 0.000 title abstract 2
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- DYFILXZSBDRFBC-UHFFFAOYSA-N 2,3,5,6-tetrahydropyrrolizin-1-one Chemical class C1CC=C2C(=O)CCN21 DYFILXZSBDRFBC-UHFFFAOYSA-N 0.000 title 1
- -1 AMINO Chemical class 0.000 abstract 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical class [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE A ES A1, A2, A3, A4 Y A5; R1 ES ALQUILO C1-C18, ALQUENILO C2-C18, ALQUINILO C2-C18 SUSTITUIDO O NO POR ALCOXILO C1-C4, ARILO C6-C18, HETEROCICLILO, ENTRE OTROS; R2 ES CICLOALQUILO C3-C18, ARILO C3-C18, HETEROCICLILO; R3 ES H, ALQUILO C1-C8, ALQUENILO C2-C8, ALQUINILO C2-C8 SUSTITUIDOS O NO POR CICLOALQUILO C3-C18, ARILO C3-C18, HETEROCICLILO; R4 ES (TRIALQUILO C1-C6)-SILILOXILO, N3, AMINO, ENTRE OTROS; R5 ES H, ALQUILO C1-C18, ALQUENILO C2-C18, ALQUINILO C2-C18 SUSTITUIDOS O NO POR ALCOXILO C1-C4, (TRIALQUILO C1-C6)-SILILOXILO, ENTRE OTROS; R6 ES OH, METOXI, O-PROPENILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (6R,7aS)-1,6-DIHIDROXI-7a-METIL-2-FENIL-5,6,7,7a-TETRAHIDRO-PIRROLIZIN-3-ONA; (S)-7a-(4-CIANO-BENCIL)-6-(3,5-DICLORO-FENIL)-7-METOXI-5-OXO-2,3,5,7a-TETRAHIDRO-1H-PIRROLIZIN-2-IL-ESTER DEL ACIDO ACETICO; ENTRE OTROS. DICHOS COMPUESTOS SON INHIBIDORES DE LFA-1 UTILES EN EL TRATAMIENTO DE CONDICIONES ALERGICAS, INFLAMATORIAS, ENFERMEDADES AUTOINMUNES, , RECHAZO DE TRASPLANTE, ENFERMEDADES ANTIPROLIFERATIVAS, ENTRE OTROS
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0520376.5A GB0520376D0 (en) | 2005-10-06 | 2005-10-06 | Organic compounds |
| GB0520379A GB0520379D0 (en) | 2005-10-06 | 2005-10-06 | Organic compounds |
| GB0520377A GB0520377D0 (en) | 2005-10-06 | 2005-10-06 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070707A1 true PE20070707A1 (es) | 2007-08-20 |
Family
ID=37507534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006001210A PE20070707A1 (es) | 2005-10-06 | 2006-10-04 | Compuestos de tetrahidro-pirrolizinona como inhibidores de lfa-1 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080262070A1 (es) |
| EP (1) | EP1937685A1 (es) |
| JP (1) | JP2009510150A (es) |
| KR (1) | KR20080050605A (es) |
| AR (1) | AR056207A1 (es) |
| AU (1) | AU2006299017B2 (es) |
| BR (1) | BRPI0616870A2 (es) |
| CA (1) | CA2624488A1 (es) |
| GT (1) | GT200600449A (es) |
| PE (1) | PE20070707A1 (es) |
| TW (1) | TW200800169A (es) |
| WO (1) | WO2007039286A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090155176A1 (en) | 2007-10-19 | 2009-06-18 | Sarcode Corporation | Compositions and methods for treatment of diabetic retinopathy |
| DE102010008644A1 (de) | 2010-02-15 | 2011-08-18 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Zyklische Ketoenole zur Therapie |
| DE102011080405A1 (de) | 2011-08-04 | 2013-02-07 | Bayer Pharma AG | Substituierte 3-(Biphenyl-3-yl)-8,8-difluor-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-one zur Therapie |
| JP2014508752A (ja) | 2011-02-17 | 2014-04-10 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 治療用の置換３−（ビフェニル−３−イル）−８，８−ジフルオロ−４−ヒドロキシ−１−アザスピロ［４．５］デカ−３−エン−２−オン |
| DE102011080406A1 (de) | 2011-08-04 | 2013-02-07 | Bayer Pharma AG | Substituierte 3-(Biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro8[4.5]dec-3-en-2-one |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4581462A (en) * | 1983-08-25 | 1986-04-08 | The Upjohn Company | Pyrrolizidine-3-ones |
| ATE292634T1 (de) * | 1999-10-20 | 2005-04-15 | Tanabe Seiyaku Co | Inhibitoren der alpha-l beta-2 vermittelten zelladhäsion |
| WO2002050080A1 (en) * | 2000-12-19 | 2002-06-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
| TW200303200A (en) * | 2002-02-07 | 2003-09-01 | Tanabe Seiyaku Co | Inhibitors of α L β 2 integrin mediated cell adhesion |
| US20030232817A1 (en) * | 2002-05-29 | 2003-12-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful for the treatment of inflammatory disease |
| US7375237B2 (en) * | 2004-08-18 | 2008-05-20 | Bristol-Myers Squibb Company | Pyrrolizine compounds useful as anti-inflammatory agents |
-
2006
- 2006-10-04 CA CA002624488A patent/CA2624488A1/en not_active Abandoned
- 2006-10-04 US US12/089,254 patent/US20080262070A1/en not_active Abandoned
- 2006-10-04 WO PCT/EP2006/009598 patent/WO2007039286A1/en active Application Filing
- 2006-10-04 EP EP06806035A patent/EP1937685A1/en not_active Withdrawn
- 2006-10-04 BR BRPI0616870-1A patent/BRPI0616870A2/pt not_active IP Right Cessation
- 2006-10-04 AR ARP060104371A patent/AR056207A1/es unknown
- 2006-10-04 AU AU2006299017A patent/AU2006299017B2/en not_active Expired - Fee Related
- 2006-10-04 JP JP2008533928A patent/JP2009510150A/ja active Pending
- 2006-10-04 PE PE2006001210A patent/PE20070707A1/es not_active Application Discontinuation
- 2006-10-04 KR KR1020087008230A patent/KR20080050605A/ko active IP Right Grant
- 2006-10-05 TW TW095137242A patent/TW200800169A/zh unknown
- 2006-10-05 GT GT200600449A patent/GT200600449A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006299017B2 (en) | 2010-11-04 |
| JP2009510150A (ja) | 2009-03-12 |
| BRPI0616870A2 (pt) | 2011-07-05 |
| CA2624488A1 (en) | 2007-04-12 |
| AR056207A1 (es) | 2007-09-26 |
| EP1937685A1 (en) | 2008-07-02 |
| US20080262070A1 (en) | 2008-10-23 |
| WO2007039286A1 (en) | 2007-04-12 |
| TW200800169A (en) | 2008-01-01 |
| GT200600449A (es) | 2007-06-11 |
| KR20080050605A (ko) | 2008-06-09 |
| AU2006299017A1 (en) | 2007-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20070707A1 (es) | Compuestos de tetrahidro-pirrolizinona como inhibidores de lfa-1 | |
| PE20120061A1 (es) | Derivados de pirimidina como antagonistas del receptor ccr2 | |
| PE20110387A1 (es) | Aminotriazolo-piridinas como inhibidores de cinasa | |
| PE20120058A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
| PE20141005A1 (es) | 1,3-oxazinas como inhibidores de bace1 y/o bace2 | |
| PE20110924A1 (es) | Derivados de 2, 4-diamino-pirimidina n2, n4-disustituidos como inhibidores de jak3 | |
| PE20080890A1 (es) | DERIVADOS DE IMIDAZOLONA E IMIDAZOLIDINONA COMO INHIBIDORES DE LA 11b-HSD1 PARA LA DIABETES | |
| PE20170679A1 (es) | Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales | |
| PE20181048A1 (es) | Amino triazoles sustituidos utiles como inhibidores de la quintinasa humana | |
| PE20110409A1 (es) | Compuestos heterociclicos antiviricos | |
| PE20142164A1 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| PE20121438A1 (es) | Derivados de imidazopiridina o imidazopirimidina como inhibidores de fosfodiesterasa 10a | |
| PE20080315A1 (es) | DERIVADOS DE PIRAZOLO-[3,4-d]-PIRIMIDINAS COMO INHIBIDORES DE CINASA PI-3 | |
| PE20091492A1 (es) | Compuestos y composiciones como inhibidores de c-kit y de la cinasa pdgfr | |
| PE20200387A1 (es) | Proceso novedoso para la elaboracion de compuestos para su uso en el tratamiento del cancer | |
| MX358149B (es) | Derivado de pirazoloquinolina. | |
| PE20110383A1 (es) | Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a) | |
| PE20120224A1 (es) | Derivados de 1h-imidazo-[4,5-c]-quinolinona | |
| PE20141588A1 (es) | Nuevos derivados de [1,2,3]triazolo[4,5-d]pirimidina como agonistas del receptor de canabinoides 2 | |
| PE20140623A1 (es) | Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2 | |
| PE20130525A1 (es) | Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih | |
| PE20090241A1 (es) | Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12 | |
| ES2422299T3 (es) | Indoles (4,5-dihidro) indoles tricíclicos | |
| PE20080839A1 (es) | Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas | |
| PE20070808A1 (es) | COMPUESTOS DERIVADOS DE ISOQUINOLINA COMO INHIBIDORES DE Rho-QUINASA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |